Literature DB >> 30117137

A Retrospective Comparative Analysis of 2D Versus 3D Laparoscopy in Total Laparoscopic Hysterectomy for Large Uteri (≥ 500g).

Rakesh Sinha1, Latika Chawla1, Shweta Raje1, Gayatri Rao1.   

Abstract

STUDY
OBJECTIVE: To evaluate the outcomes of total laparoscopic hysterectomy using 3D vision in comparison with 2D vision in women with large uteri (≥500g).
DESIGN: Retrospective analytical study Design Classification: Canadian Task Force II-1 Setting: Tertiary referral center for advanced gynecological surgery. PATIENTS: Five hundred forty six women who underwent total laparoscopic hysterectomy over a period of 13 years were studied: 301 under 2D vision and 245 under 3D vision.
INTERVENTIONS: Total laparoscopic hysterectomy Measurements: Surgical time, blood loss and complications were recorded for every case in both groups. MAIN
RESULTS: The duration of surgery for hysterectomy in the 3D laparoscopy group (88.01?36.95 min) was significantly shorter than that in the 2D group (112.61?42.59 min, p=.0001). Blood loss in the 500-1000g group was significantly less in the 3D group (p=.005). The total complication rates for 3D surgery (3.37 %) and 2D surgery (6.64%) were comparable (p=.25).
CONCLUSION: Three-dimensional laparoscopy provides stereoscopic vision and increases precision and safety. The availability of depth perception adds to the ease of surgery, especially in cases of large uteri, leading to reductions in both the duration of surgery and blood loss, which improves patient outcomes.

Entities:  

Mesh:

Year:  2018        PMID: 30117137

Source DB:  PubMed          Journal:  Surg Technol Int        ISSN: 1090-3941


  2 in total

1.  4K versus 3D total laparoscopic hysterectomy by resident in training: a prospective randomised trial.

Authors:  S Restaino; V Vargiu; A Rosati; M Bruno; G Dinoi; E Cola; R Moroni; G Scambia; F Fanfani
Journal:  Facts Views Vis Obgyn       Date:  2021-09

2.  Basic Laparoscopic Skills Training Is Equally Effective Using 2D Compared to 3D Visualization: A Randomized Controlled Trial.

Authors:  Eliana Montanari; Richard Schwameis; Nikolaus Veit-Rubin; Lorenz Kuessel; Heinrich Husslein
Journal:  J Clin Med       Date:  2020-05-10       Impact factor: 4.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.